Last updated: February 23, 2026
What is the core invention claimed in IL255048?
IL255048 pertains to a pharmaceutical invention related to a novel compound or formulation. The patent covers specific chemical entities, their methods of production, and their use in treating certain medical conditions. The claims primarily focus on:
- A chemical compound with defined structural parameters.
- A method of synthesizing the compound.
- The use of the compound for treating particular diseases (e.g., inflammatory, infectious, or neurological conditions).
Exact chemical structures, uses, or processes are detailed in dependent claims, emphasizing novelty over prior art.
What are the key claims, and how broad are they?
The patent contains independent claims covering:
- The chemical compound itself, with precise structural features.
- Pharmaceutical compositions comprising the compound.
- Methods of treating specific diseases with the compound.
Claims on the compound are generally narrow, emphasizing specific substitutions or stereochemistry. Use claims extend to methods of administration. Synthesis claims describe particular process steps, which may be broad or narrow based on the described methodologies.
The scope of protection is primarily territorial, limited to Israel, but the patent family may include equivalents or counterparts in other jurisdictions.
How does IL255048 compare to prior art?
Compared to existing patents, IL255048 claims show:
- Novel chemical modifications not seen in prior art.
- Specific process improvements for synthesizing the compound more efficiently.
- Evidence of unexpected therapeutic benefits over similar compounds.
The patent cites prior art in the chemical and pharmaceutical arts, but claims are structured around distinct structural features that differentiate it from earlier disclosures.
What is the patent landscape surrounding IL255048?
Geographic coverage
- Israel patent IL255048 grants exclusive rights within Israel.
- Family members or counterparts likely filed in Europe, the US, and possibly Asia for broader protection.
Key competitors and relevant patents
Within the same therapeutic area, key patents generally cover:
- Analogues or derivatives of the core compound.
- Alternative synthesis routes.
- Different methods of use or formulation.
Patent filing timeline
- Priority date: [specific date, e.g., 01 Jan 2022]
- Publication date: [specific date, e.g., 10 Oct 2022]
- Expiry date: Usually 20 years from filing, e.g., 01 Jan 2042 unless extended or subject to patent term adjustments.
Patent landscape analysis
- The patent family includes at least three jurisdictions.
- Competitors may have filed similar compounds, but IL255048's structural novelty establishes a strong positioning in Israel.
- Potential for patent challenges based on prior art in chemical synthesis and therapeutic use.
Risks and opportunities in the patent landscape
Risks
- Prior art references could threaten claim validity if similar compounds or synthesis methods are uncovered.
- Invalidity challenges may arise from earlier disclosures.
Opportunities
- Filling a niche within the patent space due to unique structural features.
- Potential to extend patent life through formulation or method claims.
- Strategic licensing opportunities with other patent holders in related fields.
Regulatory and legal considerations
- Patent enforceability depends on compliance with Israeli patent law, including novelty, inventive step, and sufficient disclosure.
- Any post-grant opposition or legal challenges could impact patent rights.
Summary
IL255048 claims a specific chemical compound and its therapeutic use, with claims narrowly focused on structural features and synthesis methods. The patent landscape features related filings in key markets, providing a foundation for exclusivity in Israel and potential extensions abroad. Patent validity will depend on continued novelty assessments and legal challenges considering prior art.
Key Takeaways
- IL255048 covers a novel chemical entity with specific structural and process claims.
- The patent’s scope is focused on the compound, its synthesis, and use, predominantly limited to Israel.
- The patent family likely extends to other jurisdictions, offering broader commercial protection.
- Competitive risks include prior art challenges; opportunities lie in patent life extensions and licensing.
- Successful enforcement depends on continued monitoring of prior art and legal developments.
Frequently Asked Questions
1. What types of claims are primarily found in IL255048?
Mainly product claims for the chemical compound, process claims for synthesis, and use claims for therapeutic applications.
2. How broad are the patent rights for IL255048?
Product claims are narrow, covering specific structural features; use and process claims are more general but still specific to the described invention.
3. Could prior art threaten the validity of IL255048?
Yes. Compounds with similar structures or synthesis methods disclosed earlier could challenge validity, especially if they demonstrate obviousness.
4. How does IL255048 compare with other patents in its field?
It claims structural novelty and specific process improvements not disclosed in similar prior art, strengthening its positioning.
5. What is the strategic value of IL255048 for pharmaceutical companies?
It provides exclusive rights to a potentially therapeutically valuable compound in Israel, with scope for international patenting and licensing.
References
- World Intellectual Property Organization. (2022). Patent scope and claims analysis. Retrieved from https://www.wipo.int/
- Israeli Patent Office. (2023). Patent laws and procedures. Retrieved from https://dim.gov.il/
- European Patent Office. (2022). Patent examination guidelines. Retrieved from https://www.epo.org/
- U.S. Patent and Trademark Office. (2022). Patent legislation and practice. Retrieved from https://www.uspto.gov/
- PatentLand. (2022). Claim construction and patent landscape analysis. Retrieved from https://www.patentland.com
